Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Result of Rights Issue

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT.  THIS ANNOUNCEMENT IS AN ADVERTISEMENT AND DOES NOT CONSTITUTE A PROSPECTUS OR PROSPECTUS EQUIVALENT DOCUMENT. NOTHING HEREIN SHALL CONSTITUTE AN OFFERING OF THE SECURITIES REFERRED TO IN THIS ANNOUNCEMENT. ANY DECISION TO PURCHASE, SUBSCRIBE FOR, OTHERWISE ACQUIRE, SELL OR OTHERWISE DISPOSE OF THE SECURITIES REFERRED TO IN THIS

Andreas Wallström to join Swedbank´s Macro Research team as Head of Forecasting and Deputy Head of Macro Research

Swedbank recruits Andreas Wallström as new Head of Forecasting and Deputy Head of Macro Research. Andreas comes from a role as Chief Analyst at Nordea, and has previously held several senior positions and expert assignments, i.e. at the Swedish Ministry of Finance and the European Commission.The Macro Research team is responsible for all global, regional and national macro analysis at Swedbank. The team consists of highly skilled and well-known experts, that among other things, is recognized for the Swedbank Economic Outlook (SEO); a quarterly recurrent report focusing on macro analysis of

Herantis Pharma Oyj: Manager's Transactions - Pekka Simula

Herantis Pharma Oyj: Manager's Transactions - Pekka Simula Herantis Pharma PlcCompany release 22 October 2018 at 9:00 am Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Pekka Simula Position: Chief Executive Officer Issuer: Herantis Pharma Oyj LEI: 743700W4CQVYAT3WKK38 Notification type: INITIAL NOTIFICATION Reference number: 743700W4CQVYAT3WKK38_20181020161010_2 ____________________________________________ Transaction date: 2018-10-18 Venue: FIRST NORTH

Redeye: Doro - Same ol’ situation in phones … but Care is appealing

The previous trends for Doro with stronger EBIT and negative underlying sales growth continued in Q3. We have lately become a lot more optimistic towards the future market prospects for Care, most notably related to the GreatCall bid. However, we see a risk that the traditional phones business could continue to weigh on the total.Read more in our new research update: http://bit.ly/2J81OmJ Start following companies at Redeye to receive the latest equity research within Life Science and Technology. This is a press release from Redeye - Research Powered Investment Banking. https://www.

Share buy-backs in Telia Company during week 42 2018

During the period  October 15, 2018, until October 19, 2018, Telia Company AB (publ) (LEI code 213800FSR9RNDUOTXO25) has repurchased in total 3,170,000 own shares (ISIN: SE0000667925). The share buy-backs form part of the SEK 5 billion share buy-back programme that Telia Company announced on April 20, 2018. The share buy-back programme, which runs between April 23, 2018, and March 22, 2019, is being carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 ("MAR") and the Commission Delegated Regulation (EU) No 2016/1052 (the "Safe Harbour Regulation").During the period

Fixed Price Arrangements

Oslo, 22 October 2018: Reference is made to the press release from 17 October 2018 regarding the acquisition of Shell´s Danish upstream assets. As part of the transaction Shell Trading and Supply will continue to have oil lifting rights from the assets via an offtake agreement, the parties have agreed to a fixed price arrangement under the offtake agreement for 80% of the guaranteed liquid production volumes until 30 September 2020 at current market terms. The fixed price arrangement are effective from announcement of the acquisition. Contact: Tel.: +47 22 33 60 00 or email: ir@noreco.

BerGenBio announces interim biomarker and phase II clinical data with selective AXL inhibitor bemcentinib presented at ESMO

Biomarker predicts clinical benefit rate of 70% and overall response rate of 40% in second line NSCLC. Melanoma combination study reports safety and efficacy.Bergen, Norway, 22 October 2018 - BerGenBio ASA (OSE:BGBIO) announces that the company and its collaborators have presented interim clinical and biomarker data from BerGenBio’s Phase II clinical programme with bemcentinib (BGB324), a first-in-class highly selective oral AXL inhibitor, at the ESMO 2018 Congress in Munich (19 - 23 October 2018). Additionally, a pre-clinical study in myelodysplastic syndrome (MDS) was presented. The

Multiconsult ASA profit warning

In what is a seasonally weak quarter, Multiconsult ASA expects to report a small positive EBIT for the third quarter 2018. Losses in LINK arkitektur and International segments, as well as lower than expected earnings in The Greater Oslo Area and Regions Norway are the main sources of disappointing group earnings.LINK arkitektur delivered a loss in the quarter mainly due to low project activity in Denmark as a result of unsuccessful tendering and high tendering activity in Norway. Increased project expenses combined with low project activity in Multiconsult UK and no project activity in

Lucara Announces Launch of First Sale Through Clara

VANCOUVER, October 21, 2018 /CNW/ - (LUC – TSX, LUC – BSE, LUC – Nasdaq Stockholm) Lucara Diamond Corp. (“Lucara” or the “Company”) is pleased to announce that Clara Diamond Solutions, its 100% owned digital sales platform, will commence operations in November 2018 with a select group of large vertically integrated jewelry houses and global diamond manufacturers. Clara is designed to achieve a sustainable premium over existing sales channels, including tenders and long-term supply contracts for sellers, and deliver increased margins for buyers. Eira Thomas, CEO commented: "After

BioArctic is granted a concept patent in Europe for the company’s strategy for disease-modifying treatment of Parkinson’s disease

Stockholm, Sweden, October 21, 2018 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that the European Patent Office (EPO) has issued a decision to grant the company’s patent application in Europe, EP09738534.8, for its Parkinson’s disease concept patent. The decision states that the European patent, EP 2 282 758 B1, will enter into force on November 21, 2018. The granted concept patent in Europe protects the company’s innovative treatment strategy for Parkinson’s disease. Corresponding patents have previously been granted in the US and Japan. BioArctic’s patent

Cantargia presented positive phase I clinical data with lead candidate CAN04 at ESMO

· The antibody CAN04 was well tolerated and 6 mg/kg is a safe dose · Effects on biomarkers and 5 of 13 evaluable patients achieved stable disease · 10 mg/kg currently investigated before start of phase IIa during Q4 2018 Cantargia AB (publ) today presented interim results from its clinical Phase I/II trial CANFOUR of lead candidate CAN04 (nidanilimab) in a poster presentation at the ESMO Congress 2018 in Munich, Germany. Data from 16 patients with advanced cancer treated with weekly infusions between 1 mg/kg and 6 mg/kg were presented.The poster presentation – with the title A

Catena Media agrees on amended terms for US assets acquired in December 2016

Catena Media plc (the "Company" or "Catena Media") has agreed with the sellers of U.S. assets acquired in December 2016 to amend the earn-out structure, meaning that the maximum amount of the third and final earn-out payment corresponds to USD 45 million, and that all of Catena Media's U.S. online casino and poker, as well as sports betting revenues now will be included in the calculation. The previous net profit sharing arrangement and put/call options for certain assets are terminated. Through the amended terms Catena Media obtains full control and cost certainty of the U.S. assets

Mekonomen’s rights issue oversubscribed

The information in this announcement may not be made public, announced or distributed, directly or indirectly, in or to Australia, Canada, Japan, USA or any other country where such publication or distribution would violate applicable laws or regulations. See the section Important information at the end of this press announcement. The preliminary result of the rights issue in Mekonomen AB (publ) (”Mekonomen” or the “Company”), for which the subscription period ended on 18 October 2018, shows that the rights issue is oversubscribed. As a result of the rights issue, Mekonomen will receive

Adverty receives funding of SEK 36 million before listing on Nasdaq First North

Adverty AB (publ) has during its IPO acquired a distribution of ownership to the required number of shareholders to qualify for a public listing of its share and has received a funding of SEK 36 million for its future expansion.Adverty AB (publ) (“Adverty”) has during its recent IPO acquired the required number of shareholders, in addition to its existing number of shareholders, to qualify for a public listing of the company’s share at Nasdaq First North. During the IPO period, Adverty has received funding of SEK 36 million, whereas SEK 8 million is subscribed for in the IPO, another SEK 8

Akelius lowers the risk

Akelius adjusts the finance policy.The new policy highlights the ambition to have a credit rating of BBB+ or better.The credit rating shall be minimum BBB. Starting from 2020: ‒     the loan to value should be lower than 40 percent ‒     the interest coverage ratio, excluding realized value growth, should exceed 2.0. Stockholm, 2018-10-19 Pål Ahlsén  CEO  +46 768 07 97 02  pal.ahlsen@akelius.se  This information is information that Akelius Residential Property AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was

Exercise of employee share options in Atea ASA ("the Company")

1. Employees in the Atea Group have exercised 898,905 options.Following the share option exercise the Board of Directors, pursuant to authorisation granted by the Company's Annual General Meeting, has decided to increase the Company's share capital by NOK 898,905 by issuing 898,905 new shares, of par value NOK 1. Following the increase, the Company's share capital is NOK 108,690,517 divided into 108,690,517 shares. The weighted average option exercise price is NOK 47,06. 2. Options exercised by primary insiders 19 October 2018:Aleksandr Novik has exercised 10,000 options in the

UNITED BANKERS CORPORATION: ACQUISITION OF OWN SHARES 19.10.2018

United Bankers Corporation NOTIFICATION 19.10.2018 at 18:30 UNITED BANKERS CORPORATION: ACQUISITION OF OWN SHARES 19.10.2018          Date 19.10.2018Exchange transaction BuyShare class UNIAVAmount 1,174Average price/share 7.8500 EURHighest price/share 7.8500 EURLowest price/share 7.8500 EURTotal price 9 215.90 EUR The shares held by United Bankers Corporation on 19.10.2018: UNIAV 61,867 On behalf of United Bankers Corporation Skandinaviska Enskilda Banken AB (Publ) Antti

KONE Corporation: Notice pursuant to the Finnish Securities Market Act, Chapter 9, Section 10

KONE Corporation, stock exchange release, October 19, 2018 at 6.15 p.m. EEST KONE Corporation: Notice pursuant to the Finnish Securities Market Act, Chapter 9, Section 10 KONE Corporation has received an announcement from BlackRock, Inc. on October 19, 2018, in accordance with the Finnish Securities Market Act Chapter 9, Section 5. According to the announcement, the total number of KONE Corporation shares owned by BlackRock, Inc. and its funds excluding financial instruments according to SMA 9:6a decreased below five (5) per cent of the total number of shares of KONE Corporation on

FALL for Stena Line’s Breaks to Britain this AUTUMN

From just €95 per adult sharing, price includes return ferry travel with car AND a hotel in Britain! Leading ferry company Stena Line has just announced details of its value-packed Autumn/Winter Hotel Break Sale with prices starting from as low as €95 per adult sharing which includes return ferry travel with car AND a hotel in Britain. Stena Line has secured a range of quality 3 and 4 star hotel options across Britain with literally hundreds of hotels offering everything from the tranquillity of the great outdoors to the buzz and beat of exciting city breaks in Liverpool, Manchester,

PowerCell inaugurated one of the world’s most powerful fuel cell laboratories

PowerCell Sweden AB (publ) today inaugurated its brand-new fuel cell laboratory at the company’s premises in Gothenburg, Sweden. The total investment amounts to MSEK 25 and makes it possible for PowerCell to test fuel cell stacks with an effect of up to 150 kW, which is required when developing products for larger applications such as heavy-duty trucks and buses and marine and stationary instalments.The laboratory was inaugurated at a ceremony attended by the company’s management team and employees. The new laboratory comprises two test beds, each with a testing capacity for fuel cells and

Lehto Group Plc: Lehto declines its financial outlook for the year 2018

Lehto Group PlcStock Exchange Release19 October 2018 at 5.30 p.m.Updated outlook 19 October 2018: Lehto estimates that the Group’s net sales for 2018 will grow by about 20-25% from 2017 (EUR 597.6 million in 2017) and operating profit is expected to be approximately 5-6% of net sales (2017: 10.8%). The decrease in the estimated operating profit is due to further decreased project margins, particularly in the ‘Social Care and Educational Premises’ and ‘Building Renovation’ service areas, and slightly lower estimate in the Group’s net sales. The declined net sales estimate is mainly

Yggdrasil agrees online casino content deal with Finland’s national gaming operator, Veikkaus

The game development company Yggdrasil, a Cherry AB (publ) – STO: CHER-B.ST subsidiary, has signed and finalised a deal with Finnish gaming operator Veikkaus to provide its high-quality casino games content.Veikkaus is the largest and only regulated gambling operator in Finland, both offline and online, with a turnover of EUR 3.2 billion in 2017. The company is a member of World Lottery Association and has more than two million customers. Its gaming platform www.veikkaus.fi is Finland’s largest online casino, attracting around 700,000 players every week. The operator will take Yggdrasil’

DreamHack is proud to sponsor "Årets Nätängel – Gaming"

During this year “Årets Nätängel” gala, DreamHack, in cooperation with mySafety Försäkringar, will give out a newly instituted award in the category “Årets Nätängel – Gaming”. The award has been instituted to highlight the good role models and examples within the ever-growing gaming community. Gaming is bigger than ever, making it become an immensely popular movement. According to data from Mediavision (Q4, 2017), as many as 650,000 people are watching gaming and esports in the Nordic countries every day. There are players, teams, streamers, organizations, and corporations

#18-1930 Listing of instrument issued by BNP Paribas Issuance B.V.

As from October 26, 2018, 1 instrument issued by BNP Paribas Issuance B.V. will be listed on NDX Structured Products Finland. The instrument will be registered at Euroclear Finland Oy.Issuer: BNP Paribas Issuance B.V. Agent: SIP Nordic For more details see attached file. For further information concerning this NGM notice please contact: Listing on +46 8 566 390 20 or at listings@ngm.se Nordic Growth Market NGM AB About NGM Nordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-

There are no items matching the current filter
There are no more items matching the current filter
Back to top